Replies to post #64 on Sol Global Investments Corp. (SOLCF)

[PotterBanker]

Scythian Biosciences Shifts Focus Exclusively to The United States as National Acceptance of Medical Cannabis Surges

https://globenewswire.com/news-release/2018/08/23/1555830/0/en/Scythian-Biosciences-Shifts-Focus-Exclusively-to-The-United-States-as-National-Acceptance-of-Medical-Cannabis-Surges.html

August 23, 2018 08:54 ET | Source: Scythian Biosciences Corp.

US Strategy Led by Imminent Closing of Florida Acquisition of Exclusive Medical Cannabis License

Scythian Slated for Corp Name Change to Sol Investments Corp. Following Upcoming Special Meeting

TORONTO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) has announced that its strategic focus will shift towards the burgeoning U.S. medical cannabis marketplace. Medical cannabis is currently legal in 29 U.S. States, and several key reform bills are moving through the United States Congress, including the STATES ACT (which would remove cannabis from Schedule 1 of the Controlled Substances Act in states where it is legal), the HEMP Farming Act (which would remove CBD products from Schedule 1 of the Controlled Substances Act), and several key banking and tax reform bills.

“The United States represents the single biggest opportunity in the global medical cannabis marketplace, and Scythian is excited to shift its focus to becoming one of the leading operators in the space,” CEO Rob Reid stated.